首頁 > 市場調查報告書 > 製藥

DDS 疼痛

市場調查報告書

商品編碼

1544547

止痛貼片市場、機會、成長動力、產業趨勢分析與預測，2024-2032 年

Pain Relief Patches Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月01日 | 出版商:

Global Market Insights Inc. | 英文 487 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在非處方 (OTC) 貼片的顯著進步以及對有效關節疼痛管理解決方案的需求不斷成長的推動下，全球止痛貼片市場在 2024 年至 2032 年間將呈現 6.2% 的複合年成長率。該領域不斷成長的研究和開發正在推動市場擴張。例如，2024年5月，瑞典新創公司Mucocort獲得瑞典倫理審查局和瑞典醫療產品局批准，開始對其旨在治療口瘡性口炎的口內貼劑進行臨床試驗。本試驗的主要目標是評估疼痛緩解情況。據世界衛生組織稱，到 2050 年，全球 60 歲及以上人口預計將達到 21 億，這可能會增加對疼痛管理解決方案（包括止痛貼片）的需求。

止痛貼片提供了一種方便且非侵入性的緩解疼痛的方法，使其成為尋求緩解慢性和急性疾病的消費者的首選。貼片技術和配方的創新正在提高療效和患者滿意度，為市場的大幅成長奠定了基礎。

整個止痛貼片產業根據推進劑類型、罐類型、應用和地區進行分類。

就類型而言，非處方 (OTC) 止痛貼片細分市場將在 2024 年至 2032 年間經歷大幅成長。最近的進步包括改進的黏附性能、更持久的效果以及增強活性成分的輸送。隨著消費者偏好轉向非藥物止痛選擇，非處方藥貼片因其便利性和有效性而越來越受歡迎。配方的持續創新將推動該細分市場的進一步擴張。

對於應用而言，關節疼痛領域將在預測期內顯著成長。關節疼痛通常是由關節炎或受傷等疾病引起的，需要有針對性的緩解方案。專為關節疼痛設計的止痛貼片可提供局部治療，並能以最小的副作用提供持續的緩解。經皮給藥系統和製劑的進步正在增強這些貼片的有效性，使其成為患有慢性關節疼痛的個體的首選。隨著人們對非侵入性疼痛管理意識的增強，對這些專用貼片的需求將會增加。

歐洲止痛貼片市場從2024 年到2032 年將呈現顯著的複合年成長率。。嚴格的監管框架和對消費者健康的重視正在促進先進止痛貼片的開發和採用。此外，歐洲關節疼痛的流行以及對有效非處方藥解決方案的需求不斷成長也促進了市場的成長。創新、監管和消費者需求的結合預計將推動止痛貼片市場在整個地區的擴張。

產業生態系統分析
- 影響價值鏈的因素
- 利潤率分析
- 干擾
- 未來展望
- 製造商
- 經銷商
供應商格局
利潤率分析
技術概覽
重要新聞和舉措
監管環境
衝擊力
- 成長動力
  - 慢性疼痛加劇
  - 提高消費者意識
  - 體育參與趨勢不斷成長
  - 治療技術的進步
- 產業陷阱與挑戰
  - 皮膚敏感性及不良反應
  - 監理合規性
成長潛力分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按類型，2021-2032 年

主要趨勢
處方貼劑
非處方補丁

第 6 章：市場估計與預測：按應用分類，2021-2032 年

主要趨勢
肌肉疼痛
關節痛
運動傷害
背痛
輕微疼痛

第 7 章：市場估計與預測：按包裝尺寸，2021-2032 年

主要趨勢
1 個補丁
2-5 個補丁
5-10 個補丁
超過10個補丁

第 8 章：市場估計與預測：按價格範圍，2021-2032

主要趨勢
低的
中
高的

第 9 章：市場估計與預測：按最終用途，2021-2032 年

主要趨勢
個人
商業的

第 10 章：市場估計與預測：按配銷通路分類，2021-2032 年

主要趨勢
線上
離線

第 11 章：市場估計與預測：按地區分類，2021-2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
MEA
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- MEA 的其餘部分

第 12 章：公司簡介

3M Health Care
Actavis
BioElectronics Corporation
Chattem, Inc.
Endo International plc
GlaxoSmithKline plc
Hisamitsu Pharmaceutical Co., Inc.
Johnson and Johnson
Mylan N.V.
Novartis AG
Pfizer Inc.
Reckitt Benckiser Group plc
Salonpas
Sanofi
Teva Pharmaceutical Industries Ltd.

簡介目錄

Product Code: 10077

Global Pain Relief Patches Market will exhibit a 6.2% CAGR between 2024 and 2032, fueled by significant advancements in over-the-counter (OTC) patches and increasing demand for effective joint pain management solutions. The rising research and developments in the field are driving market expansion. For instance, in May 2024, Swedish startup Mucocort was approved by the Swedish Ethical Review Authority and the Swedish Medical Products Agency to begin a clinical trial for its intraoral patch aimed at treating aphthous stomatitis. The main goal of the trial was to evaluate pain relief. According to the World Health Organization, the global population aged 60 years and older is expected to reach 2.1 billion by 2050, which will likely increase the demand for pain management solutions, including pain relief patches.

Pain relief patches offer a convenient and non-invasive method for alleviating pain, making them a preferred choice among consumers seeking relief from chronic and acute conditions. Innovations in patch technology and formulations are enhancing efficacy and patient satisfaction, positioning the market for substantial growth.

The overall Pain Relief Patches Industry is classified based on the propellant type, can type, application, and region.

In terms of type, the over-the-counter (OTC) pain relief patches segment will experience substantial growth from 2024 to 2032. OTC patches provide accessible and user-friendly pain management solutions without the need for a prescription. Recent advancements include improved adhesion properties, longer-lasting effects, and enhanced delivery of active ingredients. As consumer preference shifts towards non-pharmaceutical pain management options, OTC patches are gaining popularity for their convenience and effectiveness. Ongoing innovations in formulations will drive further market expansion in this segment.

For application, the joint pain segment will witness significant growth over the forecast period. Joint pain, often resulting from conditions such as arthritis or injuries, requires targeted relief solutions. Pain relief patches designed specifically for joint pain offer localized treatment and can provide sustained relief with minimal side effects. Advances in transdermal delivery systems and formulations are enhancing the effectiveness of these patches, making them a preferred choice for individuals suffering from chronic joint pain. As awareness of non-invasive pain management grows, demand for these specialized patches will rise.

Europe pain relief patches market will exhibit a notable CAGR from 2024 to 2032. European countries are increasingly investing in innovative pain management solutions, driven by rising healthcare awareness and a growing aging population. Stringent regulatory frameworks and an emphasis on consumer health are fostering the development and adoption of advanced pain relief patches. Additionally, the prevalence of joint pain conditions and the increasing demand for effective OTC solutions in Europe are contributing to the market's growth. This combination of innovation, regulation, and consumer demand is expected to drive the pain relief patches market expansion across the region.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Base estimates and calculations
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis, 2021-2032

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Factor affecting the value chain
- 3.1.2 Profit margin analysis
- 3.1.3 Disruptions
- 3.1.4 Future outlook
- 3.1.5 Manufacturers
- 3.1.6 Distributors
3.2 Supplier landscape
3.3 Profit margin analysis
3.4 Technological overview
3.5 Key news and initiatives
3.6 Regulatory landscape
3.7 Impact forces
- 3.7.1 Growth drivers
  - 3.7.1.1 Increasing chronic pain conditions
  - 3.7.1.2 Increasing consumer awareness
  - 3.7.1.3 Growing sports participation trends
  - 3.7.1.4 Advancements in treatment technology
- 3.7.2 Industry pitfalls and challenges
  - 3.7.2.1 Skin sensitivity and adverse reactions
  - 3.7.2.2 Regulatory compliance
3.8 Growth potential analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021-2032 (USD Million) (Thousand Units)

5.1 Key trends
5.2 Prescription patches
5.3 Over-the-counter patches

Chapter 6 Market Estimates and Forecast, By Application, 2021-2032 (USD Million) (Thousand Units)

6.1 Key trends
6.2 Muscle pain
6.3 Joint pain
6.4 Sports Injuries
6.5 Back pain
6.6 Minor aches and pains

Chapter 7 Market Estimates and Forecast, By Pack Size, 2021-2032 (USD Million) (Thousand Units)

7.1 Key trends
7.2 1 patch
7.3 2-5 patches
7.4 5-10 patches
7.5 More than 10 patches

Chapter 8 Market Estimates and Forecast, By Price Range, 2021-2032 (USD Million) (Thousand Units)

8.1 Key trends
8.2 Low
8.3 Mid
8.4 High

Chapter 9 Market Estimates and Forecast, By End-use, 2021-2032 (USD Million) (Thousand Units)

9.1 Key trends
9.2 Individual
9.3 Commercial

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2021-2032 (USD Million) (Thousand Units)

10.1 Key trends
10.2 Online
10.3 Offline

Chapter 11 Market Estimates and Forecast, By Region, 2021-2032 (USD Million) (Thousand Units)

11.1 Key trends
11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
11.3 Europe
- 11.3.1 UK
- 11.3.2 Germany
- 11.3.3 France
- 11.3.4 Italy
- 11.3.5 Spain
- 11.3.6 Russia
- 11.3.7 Rest of Europe
11.4 Asia Pacific
- 11.4.1 China
- 11.4.2 India
- 11.4.3 Japan
- 11.4.4 South Korea
- 11.4.5 Australia
- 11.4.6 Rest of Asia Pacific
11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
11.6 MEA
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 UAE
- 11.6.4 Rest of MEA